Search information pages
About Molecular Cytogenetics
This page includes information about the aims and scope of Molecular Cytogenetics, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Molecular Cytogenetics encompasses all aspects of chromosome biology and the application of molecular cytogenetic techniques in all areas of biomedicine, including structural and functional organization of the chromosome and nucleus, genome variation, expression and evolution, chromosome abnormalities and genomic variations in medical genetics and tumor genetics.
Molecular Cytogenetics primarily defines a large set of the techniques that operate either with the entire genome or with specific targeted DNA sequences.
Topical areas include, but are not limited to:
- Structural and functional organization of chromosome and nucleus
- Genome variation, expression and evolution
- Animal and plant molecular cytogenetics and genomics
- Chromosome abnormalities and genomic variations in clinical genetics
- Applications in preimplantation, pre- and post-natal diagnosis
- Applications in the central nervous system, cancer and haematology research
- Previously unreported applications of molecular cytogenetic techniques
- Development of new techniques or significant enhancements to established techniques
This journal is a source for numerous scientists all over the world, who wish to improve or introduce molecular cytogenetic techniques into their practice.
All articles published by Molecular Cytogenetics are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Molecular Cytogenetics are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
Open access publishing is not without costs. Molecular Cytogenetics therefore levies an article-processing charge of £1115/$1715/€1310 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
All articles published in Molecular Cytogenetics are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Molecular Cytogenetics include:
- Google Scholar
- Index Copernicus
- Journal Citation Reports/Science Edition
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
Molecular Cytogenetics has an unofficial Impact Factor of 1.82. BioMed Central is working with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Molecular Cytogenetics will be available.
Publication and peer review process
Criteria for publication
- Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. Reviews can cover any topical themes such as basic science and clinical reviews, ethics, pro/con debates, equipment reviews and thematic series to highlight specific topics in the field.
- Research: reports of data from original research.
- Short reports: brief reports of data from original research, usually about 1500 words.
- Methodology articles: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable, and be about 1500 words.
- Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
- Letters to the Editor: they can take three forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.
- Hypotheses: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable, and be about 1500 words.
- Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board. They focus on specific issues and are about 800 words.
Molecular Cytogenetics has a ‘closed’ peer review policy. All submitted manuscripts will be screened by the Editors-in-Chief or specialists from the Editorial board, and appropriate manuscripts will be sent for peer review. Decisions on acceptance or rejection will be based on the reports of two reviewers; a further reviewer will be invited in cases where initial reviewers disagree. Final decisions, however, rest with the Editors-in-Chief, who aim to provide an initial decision within six weeks.
Edited by Thomas Liehr, Henry Heng and Yuri Yurov, Molecular Cytogenetics is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Molecular Cytogenetics, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Molecular Cytogenetics will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Molecular Cytogenetics should adhere to BioMed Central's editorial policies.
Citing articles in Molecular Cytogenetics
Articles in Molecular Cytogenetics should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Mol Cytogenet [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Mol Cytogenet 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Molecular Cytogenetics?
Molecular Cytogenetics's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Molecular Cytogenetics offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Molecular Cytogenetics, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Molecular Cytogenetics gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other papers).
Promotion and press coverage
Articles published in Molecular Cytogenetics are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Molecular Cytogenetics's pages and on the BioMed Central homepage.
In addition, articles published in Molecular Cytogenetics may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Molecular Cytogenetics. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Molecular Cytogenetics retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.